Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01758653 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Carbon Monoxide Blood and DNA Biorepository

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv9
  2. Primary and study completion dates: Dec 2022 to Dec 2032v8
  3. Primary and study completion dates: Dec 2020 to Dec 2022v7
  4. Re-verified, no change to tracked fieldsv6
  5. Primary and study completion dates: Dec 2018 to Dec 2020v5
  6. 3 versions Re-verified since Jan 2, 2013, no change to tracked fieldsv2-v4
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this biorepository is to collect blood from patients at the time of CO poisoning and at follow-up visits months to years later. These samples can be used in the future to learn more about how CO damages the heart and brain and whether blood tests could predict which patients will have problems after CO poisoning.
Trial Details
NCT Number NCT01758653
Lead Sponsor Intermountain Health Care, Inc.
Conditions
(from sponsor)		 Carbon Monoxide Poisoning
Related terms Carbon Monoxide Poisoning
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov